ProfileGDS4718 / 220596_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 41% 40% 41% 42% 35% 39% 41% 39% 42% 41% 43% 41% 42% 41% 38% 40% 38% 43% 48% 36% 38% 41% 44% 39% 43% 44% 45% 43% 45% 39% 39% 40% 44% 41% 42% 39% 42% 40% 39% 41% 46% 37% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1766444
GSM549102patient 115, normal, homogenized [OPG study]5.0688841
GSM549104patient 119, normal, homogenized [OPG study]4.9876740
GSM549108patient 138, normal, homogenized [OPG study]5.0978341
GSM549119patient 077, normal, homogenized [OPG study]5.0854142
GSM549133patient 032, cancer, homogenized [OPG study]4.6899435
GSM549139patient 042, cancer, homogenized [OPG study]4.9378839
GSM549099patient 107, normal, homogenized [OPG study]5.043941
GSM549109patient 139, normal, homogenized [OPG study]4.9862939
GSM549110patient 046, normal, homogenized [OPG study]5.0848942
GSM549114patient 063, normal, homogenized [OPG study]5.0085841
GSM549122patient 082, normal, homogenized [OPG study]5.121443
GSM549134patient 033, cancer, homogenized [OPG study]5.0400641
GSM549136patient 036, cancer, homogenized [OPG study]5.04242
GSM549140patient 044, cancer, homogenized [OPG study]5.022241
GSM549111patient 047, normal, homogenized [OPG study]4.8817638
GSM549113patient 057, normal, homogenized [OPG study]4.9148240
GSM549132patient 031, cancer, homogenized [OPG study]4.9007338
GSM549137patient 038, cancer, homogenized [OPG study]5.0953443
GSM549142patient 047, cancer, homogenized [OPG study]5.5324548
GSM549100patient 110, normal, homogenized [OPG study]4.8191136
GSM549107patient 135, normal, homogenized [OPG study]4.8647338
GSM549115patient 068, normal, homogenized [OPG study]4.9627341
GSM549116patient 072, normal, homogenized [OPG study]5.1634644
GSM549120patient 078, normal, homogenized [OPG study]4.9442539
GSM549131patient 030, cancer, homogenized [OPG study]5.0655543
GSM549118patient 074, normal, homogenized [OPG study]5.1686844
GSM549129patient 027, cancer, homogenized [OPG study]5.2491945
GSM549123patient 088, normal, homogenized [OPG study]5.1061943
GSM549124patient 006, cancer, homogenized [OPG study]5.2969945
GSM549126patient 015, cancer, homogenized [OPG study]4.9312939
GSM549128patient 025, cancer, homogenized [OPG study]4.9361739
GSM549103patient 117, normal, homogenized [OPG study]5.0342540
GSM549117patient 073, normal, homogenized [OPG study]5.1451444
GSM549138patient 041, cancer, homogenized [OPG study]5.0210341
GSM549141patient 045, cancer, homogenized [OPG study]5.0563142
GSM549130patient 028, cancer, homogenized [OPG study]4.9705439
GSM549101patient 111, normal, homogenized [OPG study]5.1331242
GSM549105patient 128, normal, homogenized [OPG study]5.0214840
GSM549106patient 134, normal, homogenized [OPG study]4.8966939
GSM549112patient 048, normal, homogenized [OPG study]5.007241
GSM549125patient 011, cancer, homogenized [OPG study]5.2820746
GSM549127patient 024, cancer, homogenized [OPG study]4.837637
GSM549135patient 035, cancer, homogenized [OPG study]5.0643542